Thank you to our October guest bloggers, the scientists and clinicians from the Deeley Research Centre. Thanks to the talent of this team and the tremendous generosity of BC Cancer Foundation donors, immunotherapy clinical trials will be getting underway soon, for the benefit of British Columbians!

This month, we’re pleased to welcome a group that works in close collaboration with the immunotherapy clinical trials team. Scientists in Dr. Robert Holt’s laboratory at the BC Cancer Agency’s Genome Sciences Centre are experts in the field of immunogenomics – the genetic sequencing and analysis of T cells in order to enhance the anti-cancer immune response.

Join me in reading along this month to learn about their exciting role.

Lou

Lou Del Gobbo, BC Cancer Foundation
Vice President & Chief Financial Officer, BC Cancer Foundation